Cargando…
A Fusion Protein of RGD4C and β-Lactamase Has a Favorable Targeting Effect in Its Use in Antibody Directed Enzyme Prodrug Therapy
Antibody directed enzyme prodrug therapy (ADEPT) utilizing β-lactamase is a promising treatment strategy to enhance the therapeutic effect and safety of cytotoxic agents. In this method, a conjugate (antibody-β-lactamase fusion protein) is employed to precisely activate nontoxic cephalosporin prodru...
Autores principales: | Wang, Hao, Zhou, Xiao-Liang, Long, Wei, Liu, Jin-Jian, Fan, Fei-Yue |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4463609/ https://www.ncbi.nlm.nih.gov/pubmed/25927583 http://dx.doi.org/10.3390/ijms16059625 |
Ejemplares similares
-
Characterization of a fusion protein of RGD4C and the β-lactamase variant for antibody-directed enzyme prodrug therapy
por: Zhou, Xiaoliang, et al.
Publicado: (2014) -
Antibody directed enzymes revive anti-cancer prodrugs concept.
por: Bagshawe, K. D.
Publicado: (1987) -
Microbial cytosine deaminase is a programmable anticancer prodrug mediating enzyme: antibody, and gene directed enzyme prodrug therapy
por: El-Sayed, Ashraf S.A., et al.
Publicado: (2022) -
Prodrugs for Gene-Directed Enzyme-Prodrug Therapy (Suicide Gene Therapy)
por: Denny, William A
Publicado: (2003) -
Targeting assay of a fusion protein applied in enzyme prodrug therapy
por: Wang, Hao, et al.
Publicado: (2017)